Last Updated: October 2026
Moving an electronic Trial Master File (eTMF) can be a complex process that requires careful planning, coordination, and execution. A TMF is a collection of essential documents that provides evidence of trial conduct, and compliance with regulatory requirements. The Trial Master File is not just a single system but involves the use of multiple electronic systems and data collection methods. Each system used for the trial has specific structures and functions, and bringing all of them together can be challenging. In this article, we will explore some challenges you might face during a TMF migration, the overall process of TMF transfer, and some key steps and considerations for a successful transfer.
What should you consider when migrating an eTMF? Plan the migration before you move a single file: inventory every source system, confirm the receiving system is validated, map documents and metadata to the TMF Reference Model, carry the audit trail across, and reconcile record counts and IDs before sign-off. Regulators expect the transfer itself to be validated and documented, so keep evidence at each step.
In this article
- Potential challenges when migrating a TMF
- Step 1: Planning the transfer
- Step 2: Data migration
- Step 3: Validation
- Step 4: Data quality control
- Don't forget: Communication
- What regulators expect from a TMF migration
- How the main eTMF options handle migration
- How Kivo approaches TMF migration
- Frequently asked questions
Potential Challenges when Migrating a TMF
The complexity of moving a TMF can depend on several factors, including the system it is currently in and the new system to which it is being moved. Possible challenges may arise if the trial documents contained within an eTMF system at your CRO are structured differently than your/ the Sponsor’s system. Therefore, it may be difficult to manage the movement of the TMF from one system to another. Understanding the various components and how to move them at the end of a trial requires careful planning.
In addition, the various systems that may have been used during the trial can influence the way the data needs to be moved. The size and scope of the trial, the number of countries, and the number of sites involved can also influence the process. Consideration needs to be given to the regulations of moving data to ensure the proper chain of custody. The regulatory requirements must be met when transferring clinical trial data in order to maintain the integrity of the information. You can avoid this all together by having your own eTMF System.
Four problems come up again and again in practice: an index that is missing or does not match the files received; container files, such as portfolio PDFs or zipped email exports, that lose their attachments or arrive corrupted; audit trails that are missing or arrive in inconsistent formats; and duplicate documents when an open study keeps filing while the migration runs.
Below, we outline key steps typically involved in moving a Clinical trial data.
Step 1: Planning the Transfer
The first and most critical step in transferring a TMF is proper planning. It is essential to have a well-documented plan that outlines the multiple steps involved in the process to ensure the proper movement of the clinical trial data. The plan should include the number of systems that contain trial data and how that data will be moved. Maintaining the chain of custody is crucial, and the system into which it will be moved must meet all the regulatory requirements for the type of data. By carefully planning the transfer, potential issues can be identified and addressed in advance, ensuring a smoother transition.
For further information regarding the steps, you should take prior to your transfer, download the TMF Transfer Checklist.
Step 2: Data Migration
Once the transfer plan is in place, the next step is data migration. Data must be migrated from the current system to the new system or platform. This includes ensuring that the data is properly formatted and that any necessary transformations are performed. It is important to document any changes or modifications for traceability purposes. Data migration should be performed with utmost care to avoid any loss or corruption of critical trial information.
Map documents and metadata to the TMF Reference Model, and confirm which version of the model the source and destination systems each use. A mismatch between versions is a common reason a migration needs rework.
Step 3: Validation
After the data is successfully migrated, the system for the TMF data should be validated to ensure compliance with regulatory requirements for clinical trials systems. A system should be validated to ensure that it is fit for purpose and functioning properly for the data it contains. Safeguards should be in place to ensure data changes are logged and knowledge of who accessed the information can be traceable. Audit trails and robust security measures should be in place to track and monitor any changes, modifications, or access to the data. It is crucial and required for all users to be trained on the system to ensure proper management of the trial data per FDA and the final EMA guideline on computerised systems and electronic data in clinical trials (2023).
Step 4: Data Quality Control
Data quality control is an important aspect of the TMF transfer process. Once the trial data is moved to the new system, it must be checked for accuracy, completeness, and consistency to ensure that the transferred data remains complete, accurate, and reliable. Any transformation of the metadata or filing structure should be documented, and that documentation should be readily available to regulators should they request to see evidence of transfer activities. By maintaining data quality control measures, organizations can have confidence in the integrity of their trial data during and after the transfer.
Reconcile the number of records and record IDs before and after upload, and keep the reconciliation report with the migrated TMF as evidence.
Don't Forget: Communication
Effective communication is key throughout the planning and execution of the TMF transfer. All stakeholders, including sponsors, contract research organizations (CROs), and study teams need to be aware of the timelines, activities, and compliance requirements. Regular communication channels should be established to provide updates, address concerns, and ensure that everyone is aligned with the transfer process. Collaboration and transparency among all parties involved can help mitigate potential issues and ensure a successful transfer.
What Regulators Expect from a TMF Migration
The EMA guideline on computerised systems and electronic data in clinical trials says the process of data transfer between systems should be validated to ensure the data remain accurate. It treats migration as permanently moving existing data, including metadata, into another system, expects archived data to be read-only, and expects an audit trail covering the creation and modification of electronic data.
FDA's final October 2024 guidance, Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers, says documentation should cover data migration, retention, backup, recovery, and contingency plans. Records should not be altered in value or meaning during transfer, data can be moved to a different durable repository using a validated process, and audit trail documentation must be kept at least as long as the records themselves.
ICH E6(R3) is also now final. FDA posted it on September 9, 2025, and the EMA made it effective on July 23, 2025. Check FDA's current status for a U.S. compliance date, and confirm requirements with your regulatory team.
How the Main eTMF Options Handle Migration
This is a neutral overview, not a ranking. It does not assess implementation quality, market share, or fit for your organization. Capabilities change, so confirm details with each vendor. Kivo is our product, so read this section with that in mind.
| Option | What it is | Migration / transfer support | Source of claim |
|---|---|---|---|
| Kivo eTMF | Cloud eTMF on the same platform as DMS, RIM, and QMS | Validated migration ingests documents, metadata, and audit trails from most TMF platforms and CROs via secure FTP and recompiles one unified audit trail. Elevar Therapeutics moved 19 TMF studies (73,794 documents) in 72 days. | kivo.io |
| Veeva eTMF | Cloud eTMF from Veeva | Product page lists a TMF Transfer feature for sending completed TMFs between sponsors and CROs at study close. Migration steps are not described on the page. | veeva.com (checked October 2026) |
| Montrium eTMF | Cloud eTMF with eTMF Connect from Montrium | Site says implementation typically takes 4-8 weeks, depending on the volume of documents to migrate. No migration method is published on the homepage; confirm with Montrium. | montrium.com (checked October 2026) |
| Ennov eTMF | eTMF from Ennov, with a separate eTMF Archive product | Lists a migration service. No method is described on the homepage; confirm with Ennov. | en.ennov.com (checked October 2026) |
Whichever option you choose, ask five questions: Does the audit trail survive the transfer intact? Can you QC files before sign-off? Is the receiving system validated? Are documents mapped to the TMF Reference Model? Will you receive a reconciliation report?
How Kivo Approaches TMF Migration
Moving a TMF is a complex process that requires careful planning, coordination, and execution. Kivo's validated migration ingests documents, metadata, and audit trails from most TMF platforms and CROs through secure FTP, and recompiles a single unified audit trail even for documents that passed through several prior systems. Elevar Therapeutics used it to migrate 19 TMF studies in 72 days. Kivo holds SOC 2 Type 2 and ISO 9001 certifications, is rated 4.9/5 on G2, and supports 200+ teams. Learn more about Kivo's TMF transfer and eTMF.
Ensuring the activities are traceable will provide assurance that the data has maintained chain of custody. The Trial Master File is the evidence of the trial conduct and should be a comprehensive collection of documentation for trial activities. As such a valuable asset to the company, planning ahead for the TMF Transfer is a critical step in the Clinical Trial lifecycle.
For further information on how to prepare for and execute a TMF migration, contact the Kivo team.
Frequently Asked Questions
What is a TMF migration?
Moving a trial master file, including documents, metadata, and audit trails, from one system or holder to another, such as from a CRO's eTMF to the sponsor's.
How long does an eTMF migration take?
It depends on document volume, source quality, and study status. Open studies need a frozen source; closed studies need QC and reconciliation. Ask vendors for a scoped plan rather than a generic number.
Does the audit trail have to migrate?
Regulators expect audit trail documentation to be kept as long as the records, and migration should not alter records in value or meaning. Carry the source audit trail across, or preserve it in a retrievable form.
Which guidance applies to a TMF migration?
EMA's 2023 computerised systems guideline, FDA's October 2024 electronic systems Q&A, and ICH E6(R3). Confirm current requirements with your regulatory team.
Related reading: Best practices for end of study TMF transfer | What it takes to move your TMF from paper to digital | What it takes to validate an in-house eTMF system | Aligning eTMF with the CDISC TMF Reference Model
